Sign Up for Generic Drug Makers (State AGs) Class Action Lawsuit
Generic Drug Makers (State AGs) class action lawsuit is currently open:
Those who meet eligibility criteria should apply before the deadline March 4, 2027. Generic drug price-fixing settlement: state attorneys general set aside $29.3 million for people who bought any of about 200 generics. See who can claim.
Generic Drug Makers (State AGs) Class Action Lawsuit
If you filled a prescription for a common generic drug such as doxycycline, pravastatin, glyburide or levothyroxine between 2009 and 2019, three lawsuits say you may have paid more than you should have. This is not a class action. It is a recovery by state attorneys general, who sued generic drug manufacturers to get money back for the people who live in their states.
The lawsuits claim the manufacturers and their alleged co-conspirators agreed to fix prices and split up customers instead of competing. According to the states' court filings, the first case, filed in December 2016, centers on agreements involving Heritage Pharmaceuticals and now covers 15 drugs. The second, filed in 2019, centers on Teva and covers more than 100. The third, filed in 2020, covers more than 80, mostly skin treatments. The lawsuits do not question the safety or effectiveness of any of the drugs.
All three cases are before Judge Michael P. Shea in the U.S. District Court for the District of Connecticut, as case numbers 3:16-cv-02056, 3:19-cv-00710 and 3:20-cv-00802. They are brought under federal antitrust law and state antitrust and consumer protection laws. The manufacturers deny doing anything wrong, and the settlements carry no admission of liability. The cases continue against companies that have not settled, including Teva, Sandoz, Mylan and Pfizer. A private class action over the same purchases, In re Generic Pharmaceuticals Pricing Antitrust Litigation in federal court in Pennsylvania, is a separate case with its own claims process and dates, and a claim filed here is not a claim there.
Generic Drug Makers (State AGs) Class Action Settlement - $29,347,208
The state attorneys general have set aside $29,347,208 for consumers from four settlements: $17,624,403 from Apotex, $6,085,800 from Lannett, $3,833,998 from Heritage, Emcure and Satish Mehta, and $1,803,008 from Bausch. Lannett pays in yearly installments over six years with interest, which the states say brings its consumer share to $7,343,525. A fifth settlement, with Glenmark, would add about $13.3 million for consumers. The court gave it preliminary approval on August 6, 2026 and set a final hearing for November 5, 2026, so that money is still pending.
The companies are paying more than that in total: $39.1 million from Apotex, $13.77 million from Lannett, $10 million from Heritage and $4.08 million from Bausch. The notice says roughly 45% of the settlement payments goes to consumers. In the Apotex settlement, about 25% goes to state agencies and 30%, or $11.73 million, goes into a cost account for notice, administration and the states' cost of litigating, including attorney fees. Apotex also agreed not to fix prices, rig bids or divide up markets for generic drugs for seven years.
The settlements cover purchases from May 1, 2009 to December 31, 2019. Claims opened on September 22, 2026. The deadline to file with Chimo is March 4, 2027. The court will consider the plan for paying the money out at a hearing on September 8, 2027 at 10:00 a.m. in Hartford, Connecticut. More money may follow because the cases continue against the other manufacturers, but the notice says further recoveries are not guaranteed.
Deadline for filing a claim: March 4, 2027
Generic Drug Makers Class Action Payout: $12 - $59 (estimate)
The plan does not set a payment amount, and nobody knows it yet. It depends mostly on how many valid claims come in. Most people choose between two options. Option 1 is an equal share with everyone else who picks it, and asks for no purchase details. Option 2 is a share based on your own estimate of what you paid out of pocket for the covered drugs. The plan says an Option 2 payment will not be less than an Option 1 payment and may be more.
Our estimate is about $12 to $59 for an average claim: $29,347,208 spread across 500,000 valid claims is about $59 each, and across 2,400,000 valid claims it is about $12. No claim count has been published, so both counts are our assumptions, not the court's. Glenmark's roughly $13.3 million would raise the figures if approved, and Option 2 claims can receive more than the equal share. Residents of Alabama, Arkansas, Hawaii and Texas get a fixed amount instead, to be set at final approval and paid only from the Apotex money. Residents of Louisiana and Missouri share only in the Heritage and Apotex money.
Payment is by PayPal, Venmo, Zelle or a mailed check. The plan says checks may be held back so payments can be combined, possibly for months. Eligible payments are sent only after the claim deadline passes, claims are reviewed, disputes are resolved and the court gives the plan final approval. Once a payment is issued there are 180 days to accept it or cash the check before it is canceled. The same claim form counts toward later distributions.
Generic Drug Makers Class Action Eligibility
You may qualify if you bought at least one of the covered generic prescription drugs in the United States between May 1, 2009 and December 31, 2019. The list runs to about 200 drugs and forms, including doxycycline, pravastatin, glyburide, levothyroxine, gabapentin tablets, warfarin and amphetamine/dextroamphetamine. The drug has to have been made by one of the manufacturers that were sued, though not necessarily one that settled, because the states are pooling the money. Brand-name drugs do not count.
Where you live when you file decides which money you can share in, not where you bought the drug. Residents of most states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands and the Northern Mariana Islands can share in every settlement. Residents of Louisiana and Missouri share in two of them, and residents of Alabama, Arkansas, Hawaii and Texas file a simplified claim. Drugs bought outside the United States, to resell, or directly from a manufacturer are not covered, and the manufacturers' officers and employees cannot claim.
No receipts are required. The form asks for your contact details, date of birth and payment method. For Option 2 it also asks for one dollar figure, your estimated out-of-pocket spending on the covered drugs. You then sign to say that everything on the form is true and correct, which the form calls a certification. The claims administrator screens claims for fraud and can ask an Option 2 claimant for records. You get 21 days to respond, and a claim that is not backed up can be adjusted, moved to Option 1 or rejected. Estimate honestly and claim the number you are confident in.
Generic drugs covered by the settlements
Drug and form, as listed in the court notice
Acetazolamide
Acetazolamide Tablet 125 mg
Acetazolamide Tablet 250 mg
Adapalene Cream 0.1%
Adapalene Gel
Alclometasone Dipropionate Cream 0.05%
Alclometasone Dipropionate Ointment
Amiloride HCL/HCTZ Tablets
Show all 215Show fewer
Ammonium Lactate Cream EQ 12% Base
Ammonium Lactate Lotion EQ 12% Based
Amoxicillin/Clavulanate Chewable Tablets
Amphetamine/Dextroamphetamine ER (aka Mixed Amphetamine Salts)
Amphetamine/Dextroamphetamine IR
Azithromycin Suspension
Azitlnomycin Oral Suspension
Baclofen Tablets
Benazepril HCTZ
Betamethasone Dipropionate Cream EQ 0.05% BASE
Betamethasone Dipropionate Cream, Augmented EQ 0.05% BASE
Betamethasone Dipropionate Lotion EQ 0.05% BASE
Betamethasone Dipropionate Lotion, Augmented EQ 0.05% BASE
Betamethasone Valerate Cream 0.01% BASE
Betamethasone Valerate Lotion 0.01% BASE
Betamethasone Valerate Ointment 0.01% BASE
Betamethasone Valerate Tablet 0.01% BASE
Bethanechol Chloride Tablets
Bromocriptine Mesylate Tablets EQ 2.5 mg Base
Budesonide DR Capsules
Budesonide Inhalation
Bumetanide Tablets
Buspirone Hydrochloride Tablets
Cabergoline
Calcipotriene Betamethasone Dipropionate Ointment 0.06-0.005%
Calcipotriene Solution 0.005%
Capecitabine
Carbamazepine Chewable Tablets
Carbamazepine ER Tablets 100mg; 200mg; 400mg
Carbamazepine Tablets
Cefdinir Capsules
Cefdinir Oral Suspension
Cefpodoxime Proxetil Oral Suspension EQ 100mg Base; EQ 50mg Base
Cefpodoxime Proxetil Tablets EQ 100mg Base; EQ 200 mg Base
Cefprozil Tablets
Celecoxib
Cephalexin Suspension
Chlorpromazine HCL
Cholestyramine
Ciclopirox Cream 0.77%
Ciclopirox Shampoo 1%
Ciclopirox Solution 8%
Cimetidine Tablets
Ciprofloxacin Tablets
Clarithromycin ER Tablets
Clemastine Fumarate Tablets
Clindamycin Phosphate 60 ml solution
Clindamycin Phosphate All except solution (Cream, Gel, Lotion)
Clindamycin Phosphate All formulations (Cream, Gel, Lotion, Solution)
Clobetasol Propionate Cream 0.05%
Clobetasol Propionate Gel 0.05%
Clobetasol Propionate Ointment 0.05%
Clobetasol Propionate Solution 0.05%
Clomipramine HCL
Clonidine TTS Patch
Clotrimazole Betamethasone Dipropionate Cream EQ 0.05% BASE
Clotrimazole Betamethasone Dipropionate Ointment EQ 0.05% BASE
Clotrimazole Topical Solution
Cyproheptadine HCL Tablets
Desmopressin Acetate-Tablets
Desogestrel/Ethinyl Estradiol Tablets (Kariva)
Desonide Cream 0.05%
Desonide Lotion 0.05%
Desonide Ointment 0.05%
Desoximetasone Ointment 0.05%; 0.25%
Dexmethylphenidate
Dextroamphetamine Sulfate ER
Diclofenac Potassium Tablets
Diclofenac Tablets
Dicloxacillin Sodium Capsules
Diflunisal Tablets
Diltiazem HCL Tablets
Disopyramide Phosphate Capsules
Doxazosin Mesylate Tablets
Doxycycline hyclate DR
Doxycycline monohydrate
Drospirenone and ethinyl estradiol (Ocella)
Econazole Nitrate Cream 1%
Enalapril Maleate Tablets
Entecavir
Epitol Tablets
Eplerenone Tablets 25mg; 50mg
Erythromycin Base/Ethyl Alcohol Solution 2%
Estazolam Tablets
Estradiol
Estradiol Tablets
Ethambutol HCL [hydrocholoride] Tablets 100mg; 400mg
Ethinyl estradiol and levonorgestrel (Portia and Jolessa)
Ethosuximide Capsules
Ethosuximide Oral Solution
Etodolac ER Tablets
Etodolac Tablets
Fenofibrate
Fluconazole Tablets
Fluocinolone Acetonide Cream 0.01%; 0.025%
Fluocinolone Acetonide Ointment 0.025%
Fluocinonide Cream
Fluocinonide Cream 0.05%; 0.1%
Fluocinonide Emolient Cream
Fluocinonide Gel
Fluocinonide Gel 0.05%
Fluocinonide Ointment
Fluocinonide Ointment 0.05%
Fluocinonide Solution 0.05%
Fluoxetine HCL Tablets
Flurbiprofen Tablets
Flutamide Capsules
Fluticasone Propionate Lotion (60ml) 0.05%
Fluvastatin Sodium Capsules
Fosinopril-hydrochlorothiazide
Gabapentin Tablets
Glimepiride Tablets
Glipizide-metformin
Glyburide
Glyburide-metformin
Griseofulvin Microsize Tablets 250mg; 500mg
Griseofulvin Suspension
Halobetasol Propionate Cream 0.05%
Halobetasol Propionate Ointment 0.05%
Haloperidol
Hydrocortisone Acetate Suppositories (Anucort HC) Suppository 25mg; 30mg
Hydrocortisone Valerate Cream 0.2%
Hydroxyurea Capsules
Hydroxyzine Pamoate Capsules
Imiquimod Cream 0.2%
Irbesartan
Isoniazid
Ketoconazole Cream
Ketoconazole Cream 2%
Ketoconazole Tablets
Ketoprofen Capsules
Ketorolac Tromethamine Tablets
Labetalol HCL Tablets
Lamivudine/Zidovudine (generic Combivir)
Latanoprost Drops/Solution 0.005%; 0.01%
Leflunomide
Levothyroxine
Lidocaine Ointment 5%
Loperamide HCL Capsules
Medroxyprogesterone Tablets
Meprobamate
Methazolamide Tablets 25mg; 50mg
Methotrexate Tablets
Methylphenidate HCL ER Tablets 10mg; 20mg; 5mg
Methylphenidate HCL Tablets 10mg; 20mg; 5mg
Metronidazole Cream 0.75%
Metronidazole Gel 0.75%
Metronidazole Gel 1%
Metronidazole Lotion 0.75%
Mimvey (Estradiol/Noreth) Tablets
Moexipril HCL Tablets
Moexipril HCL/HCTZ Tablets
Mometasone Furoate Cream 0.1%
Mometasone Furoate Ointment 0.1%
Mometasone Furoate Solution 0.1%
Nabumetone Tablets
Nadolol Tablets
Nafcillin Sodium Injectable Vials EQ 10GM Base; EQ 1GM Base; EQ 2GM Base
Niacin ER Tablets
Nimodipine
Nitroforantoin MAC Capsules
Norethindrone/ethinyl estradiol (Balziva)
Northindrone Acetate
Nortriptylline Hydrochloride Capsules
Nystatin
Nystatin Ointment 100,000 UNITS/GM
Nystatin/Triamcinolone Acetonide Cream - 100,000 UNITS/GM, 0.1%; 100,000 UNITS/GM, 1%
Nystatin/Triamcinolone Acetonide Ointment -100,000 UNITS/GM, 0.1%; 100,000 UNITS/GM, 1%
Omega-3-Acid Ethyl Esters
Oxacillin Sodium Injectable Vials - EQ 10GM Base; EQ 1GM Base; EQ 2GM Base
Oxaprozin Tablets
Oxybutynin Chloride Tablets
Paricalcitol
Paromomycin
Penicillin VK Tablets
Pentoxifylline Tablets
Phenytoin Sodium ER Capsule – 100mg; 200mg; 300mg
Pioglitazone HCL Metformin HCl Tablets 500mg, EQ 15mg Base; 850MG; EQ 15mg Base
Piroxicam
Pravastatin Sodium Tablets
Prazosin HCL Capsules
Prochlorperazine Maleate Suppository – 25mg
Prochlorperazine Tablets
Promethazine HCL Suppositories12.5mg; 25mg
Propranolol HCL Tablets
Raloxifine HCL Tablets
Ranitidine HCL Tablets
Tacrolimus Ointment – 0.03%; 0.1%
Tamoxifen Citrate Tablets
Temozolomide
Terconazole Cream 0.8%
Theophylline
Tizanidine
Tobramycin
Tolmetin Sodium Capsules
Tolterodine ER
Tolterodine Tartrate
Topiramate Sprinke Capsules
Triamcinolone Acetonide
Triamcinolone Acetonide Cream - 0.8%; 0.025%; 0.1%; 0.5%
Triamcinolone Acetonide Ointment - 0.025%; 0.1%; 0.5%
Triamcinolone Acetonide Paste – 0.1%
Trifluoperazine HCL
ValsartanHCTZ
Verapamil
Warfarin Sodium Tablets
Zoledronic acid
Generic Drug Makers Class Action Claim Form
1
2
3
FAQ
It is a recovery by state attorneys general, not a class action. They sued generic drug manufacturers in federal court in Connecticut, and settlements with Heritage, Apotex, Bausch and Lannett have set aside $29,347,208 for people who bought the drugs.
People who bought a covered generic prescription drug in the United States between May 1, 2009 and December 31, 2019, not for resale. Where you live when you file decides which settlements you share in, and residents of a few states get less.
About 200 drugs and forms are on the list in the court notice. They include doxycycline, pravastatin, glyburide, levothyroxine, gabapentin tablets, fluconazole tablets and warfarin. The lawsuits do not question the safety of any of these drugs.
No amount is set. Our estimate is about $12 to $59 for an average claim: $29,347,208 divided across 2,400,000 or 500,000 valid claims. The claim counts are our assumptions, since none has been published. Yours could be higher or lower.
Option 1 is an equal share and asks for no purchase details. Option 2 is based on your estimate of what you paid out of pocket for the covered drugs, and the plan says it will not pay less than Option 1. If you pick neither, you are placed in Option 1.
No receipts are required to file. If you choose Option 2, the claims administrator may later ask for records to support your estimate. You would have 21 days to respond, and a claim that is not backed up can be adjusted or moved to Option 1.
The deadline to file with Chimo is March 4, 2027. Claims opened on September 22, 2026. A valid claim filed on time is included in the first distribution, and the notice says the same claim form is also considered for any future distributions.
Not before the court approves the plan. That hearing is set for September 8, 2027. Eligible payments are sent after claims are reviewed and disputes are resolved. The plan says mailed checks may come months later than PayPal, Venmo or Zelle payments.
No. In re Generic Pharmaceuticals Pricing Antitrust Litigation, in federal court in Pennsylvania, is a separate private class case over the same purchases. It has its own claims process and its own dates, and a claim filed here is not a claim there.
Chimo is a private company that helps people file. We prepare your claim and mail it to the claims administrator, and filing is included in a membership. Anyone eligible can also file with the claims administrator directly. Chimo is not part of the case.
Sources
These are the court's own records for this case. They are hosted here unchanged, so you can check anything on this page against the documents themselves.
- Complaint (State of Connecticut et al. v. Aurobindo Pharma USA, Inc. et al.) (PDF) Complaint · Filed December 15, 2016 · U.S. District Court, District of Connecticut · Case 3:16-cv-02056
- Order Granting Final Approval of the Bausch and Lannett Settlements (PDF) Court order · Filed May 27, 2026 · U.S. District Court, District of Connecticut · Case 3:16-cv-02056
- States' Memorandum in Support of Final Approval of the Bausch and Lannett Settlements (PDF) Court record · Filed May 20, 2026 · U.S. District Court, District of Connecticut · Case 3:16-cv-02056
The full case file is on the court docket: view the docket.